ChiCTR2000030117  2020/2/23  Jiangxi Qingfeng Pharmaceutical Co., Ltd. (Ganzhou, China)  A multicenter, randomized, open, parallel controlled trial for the evaluation of the effectiveness and safety of Xiyanping injection in the treatment of common type novel coronavirus pneumonia (COVID-19)